Market revenue in 2023 | USD 1,266.6 million |
Market revenue in 2030 | USD 2,086.7 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Logistics & distribution |
Fastest growing segment | Logistics & distribution |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.34% in 2023. Horizon Databook has segmented the U.S. clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. clinical trial supply and logistics market is anticipated to witness significant growth rate over the forecast period. The U.S. is the hub for operation of major players in supply and logistics market such as Labcorp Drug Development, PAREXEL International Cooperation, Thermo Fisher Scientific, Inc., and Marken.
Moreover, it has strong infrastructure, availability of necessary funds, and the ability to adapt to advance technology. In the past few years, a trend has been observed of shifting clinical trials site outside the U.S., which significantly reduces the cost. Furthermore, wide variation in diseases can be observed in population of other countries in comparison with the U.S.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. clinical trial supply & logistics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account